Mammography Should Remain Primary Diagnostic Tool for Detecting Breast Cancer in Symptomatic Male Patients, Study Suggests

Thursday, December 1, 2016

MedPage Today (11/28, Susman) reports that research suggests “mammography should remain the primary diagnostic tool for detecting breast cancer in symptomatic male patients, and there was no added value to incorporating ultrasound as part of the initial exam.” The findings were presented at RSNA 2016. The researchers wrote, “The American College of Radiology [ACR] Appropriateness Criteria provide strong support for diagnostic mammography as the initial examination in the symptomatic male >25 years of age, but are less clear in the role of ultrasound in this clinical setting.” 

Automated Volume Breast Ultrasound Equals Hand-Held Ultrasound in Accuracy, Researchers Say

Monday, November 28, 2016

Diagnostic Imaging (11/27) reports, “Automated volume breast ultrasound (AVBS) is equal in diagnostic accuracy to hand-held (HH) ultrasound, whether performed by a sonographer or mammography technologist,” researchers found. The findings of the 90-patient study were presented at the RSNA 2016 meeting. 

Study Suggests There’s No Evidence Women 75 and Older Should Discontinue Regular Mammography Screening

Monday, November 28, 2016
Aunt Minnie (11/28) reports, “There’s no evidence that women 75 and older should discontinue regular mammography screening, according to a study presented at RSNA 2016.” Investigators “found that women between the ages of 75 and 90 continue to benefit from screening.” 

CDC Predicts Cancer May Overtake Heart Disease as Leading Cause of Death

Friday, November 18, 2016
According to the Washington Post (11/17, Sun), “in a report published” yesterday, “the Centers for Disease Control and Prevention analyzed data for the five leading causes of death in 2014 in the United States, which together account for 63 percent of all deaths.” The report indicates that “fewer people are dying prematurely from three of the five leading causes of death between 2010 and 2014: cancer, stroke and heart disease.” However, “there was a significant increase in preventable deaths from unintentional injuries, mostly because deaths from opioid overdoses are increasing.”

Younger Patients with Early Breast Cancer, Low-Risk DCIS May Qualify for APBI, ASTRO Recommends

Friday, November 18, 2016

MedPage Today (11/17, Bankhead) reports, “Younger patients with early breast cancer and those with low-risk ductal carcinoma in situ (DCIS) can qualify for accelerated partial breast irradiation (APBI), according to an updated consensus statement from the American Society for Radiation Oncology (ASTRO).” The updated guidance “identified patients ≥50 as ‘suitable’ for APBI, which received a ‘cautionary’ recommendation for women 40 to 49 who met all other elements of suitability.” The expert panel “that developed the statement found women younger than 40 unsuitable for APBI.”